2025-06-03 – Press Releases – www.prnewswire.com

YANTAI, China, June 3, 2025 /PRNewswire/ — On June 2 (Chicago time), in an oral presentation at the 2025 ASCO Annual Meeting, Dr. Lin Shen from Beijing Cancer Hospital presented the results of a Phase 2 clinical study conducted in China evaluating the efficacy and safety of disitamab…

Read the full article here.

About Us

Your go-to source for comprehensive research and comparisons of top-quality health supplements. We provide unbiased insights through meticulous analysis, offering accurate, evidence-based information to help you make informed decisions.

References

Awards

© 2024 by Health Supplements Review.